PCE release, Apple's Chinese sales, European earnings - what's moving markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Colgate-Palmolive Company (CL) PT Raised to $115 at TD Cowen
July 29, 2024 1:10 PM EDTTD Cowen analyst Robert Moskow raised the price target on Colgate-Palmolive Company (NYSE: CL) to $115.00 (from $110.00) while maintaining a Buy rating.
The analyst comments "Colgate delivered a high quality 2Q and raised guidance meaningfully. Consistent with our positive thesis, volume growth continued to... More
Bristol-Myers Squibb Co. (BMY) PT Raised to $57 at Goldman Sachs
July 29, 2024 7:18 AM EDTGoldman Sachs analyst Chris Shibutani raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $57.00 (from $55.00) while maintaining a Buy rating.
The analyst comments "BMY's noteworthy outperformance on Friday July 26 (+~11% vs. flat XLV), while it occurred amidst favorable shifts in the broader market macro backdrop, was earned, in our... More
3M (MMM) PT Raised to $95 at RBC Capital
July 29, 2024 6:33 AM EDTRBC Capital analyst Deane Dray raised the price target on 3M (NYSE: MMM) to $95.00 (from $93.00) while maintaining a Underperform rating.
The analyst comments "Underperform-rated 3M reported strong 2Q24 revenue/margin upside across the portfolio in CEO Bill Browns debut quarter. Heres what drove the... More
Colgate-Palmolive Company (CL) PT Raised to $101 at Jefferies
July 29, 2024 6:06 AM EDTJefferies analyst Kaumil Gajrawala raised the price target on Colgate-Palmolive Company (NYSE: CL) to $101.00 (from $95.00) while maintaining a Hold rating.
The analyst comments "Colgate had to deliver a perfect qtr to sustain its 27x NTM P/E multiple. They did. Brand reinvestments are working,... More
Colgate-Palmolive Company (CL) PT Raised to $112 at Evercore ISI
July 29, 2024 5:34 AM EDTEvercore ISI analyst Robert Ottenstein raised the price target on Colgate-Palmolive Company (NYSE: CL) to $112.00 (from $106.00) while maintaining a Outperform rating.
The analyst comments "Friday, Colgates shares closed at a 30% premium to Staples, 5 points above its 20-year trading range. We do not expect CL to regress... More
Deutsche Bank Upgrades 3M (MMM) to Buy
July 29, 2024 4:56 AM EDTDeutsche Bank analyst Nicole DeBlase upgraded 3M (NYSE: MMM) from Buy to Buy with a price target of $150.00 (from $110.00).
The analyst comments "Since Bill Brown's appointment to the CEO role in mid-March, we have heard nothing but positive anecdotes from colleagues and investors about his legacy at L3Harris (ticker:... More
Stifel on Colgate-Palmolive Company (CL): 'Lifting Estimates on Solid 2Q with Volume, EBIT Outperformance'
July 26, 2024 2:20 PM EDTStifel analyst Mark Astrachan reiterated a Buy rating and $105.00 price target on Colgate-Palmolive Company (NYSE: CL).
The analyst comments "We lift 2024-2025 EPS estimates and maintain our Buy rating and $105 price target, 17x 2025E EBITDA, following strong 2Q24 results with sales and... More
Apple stock now seen as 'a more stable AI play for volatile times'
July 26, 2024 8:41 AM EDTRaymond James analysts have lifted their stock price target on Apple (NASDAQ: AAPL) to $250 from $200 a share, describing the company as "a more stable AI play for volatile times."
The firm, which maintained an Outperform rating on the stock, said in its F3Q24 preview that it expects a slight beat in results and an outlook largely in line with previous expectations.
This optimism... More
Bristol-Myers Squibb (BMY) stock gains after raising full-year guidance
July 26, 2024 7:51 AM EDTBristol-Myers Squibb (NYSE: BMY) shares rallied more than 5% premarket Friday as the company reported a robust second quarter, surpassing Wall Street's expectations for both earnings and revenue, and raised its full-year guidance.
The pharmaceutical giant posted adjusted earnings per share (EPS) of $2.07, significantly higher than the analyst estimate of $1.64. Revenue for the quarter was also strong at $12.2 billion, beating the consensus estimate of $11.52 billion and marking a 9% increase from the same quarter last year, or an 11% rise adjusting for foreign exchange.
The company's performance was propelled by its Growth Portfolio, which saw... More
Apple to assemble iPhone 16 Pro and Pro Max models in India: report
July 26, 2024 7:25 AM EDTApple (NASDAQ: AAPL) is set to significantly expand its manufacturing footprint in India by assembling its high-end iPhone 16 Pro and Pro Max models for the first time, according to a report by website Money Control on Friday.
According to the publication, citing sources, the move will come through its partner Foxconn and marks a strategic shift away from... More
3M Co. (MMM) raises full-year EPS guidance, tops earnings and revenue expectations
July 26, 2024 6:55 AM EDTIndustrial conglomerate 3M Co. (NYSE: MMM) reported a robust second quarter, with earnings and revenue surpassing Wall Street estimates, prompting the company's shares to jump 5.4% in response.
The company's adjusted earnings per share (EPS) from continuing operations climbed 39% to $1.93, exceeding the analyst consensus of $1.67. Revenue held steady at $6.3 billion, topping expectations by $430 million and... More

